Page 28 - Management of Advanced Urothelial Carcinoma: Emerging Therapies and Biomarkers
P. 28
Erdafitinib Dosage and Administration
Recommended Dosage and Schedule
• Recommended starting dose: 8 mg (two 4 mg tablets) orally, once daily, with food
• Phosphate intake should be restricted to 600 – 800 mg daily (all patients)
• If vomiting occurs, next dose should be taken the next day
• Missed dose: take as soon as possible on the same day. Resume regular daily dose schedule the next day
(extra tablets should not be taken to make up for the missed dose)
• Treatment should continue until disease progression or unacceptable toxicity occurs
Dose Increase Based on Serum PO Levels
4
Start erdafitinib Determine serum • Increase the dose of erdafitinib to 9 mg once daily if:
(8mg) PO 4 level
• Serum PO level is <5.5 mg/dL
8 mg 4
• No ocular disorders or ≥Grade 2 adverse reactions
• A dose increase occurred in 41% of patients based on the
Day 1 Day 9 mg
14–21 Day 14 – 21 serum PO level
4
Janssen Inc. Product Monograph: Balversa. Janssen Canada Inc; 2019